NervGen Pharma's total assets for Q4 2025 were C$23.21M, an increase of 11.85% from the previous quarter. NGEN total liabilities were C$19.73M for the fiscal quarter, a 29.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.